Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FTC: Pay-to-Delay Pharma Deals Cover $8.3 Billion in Revenue
Yahoo/YCharts
Friday, January 18, 2013 - 9:18am
tags:
FTC, pay-for-delay
AbbVie, Abbott Spinoff, Starts Life Near Top of Pharma Industry’s Dividend-Yield Heap
Yahoo/YCharts
Friday, January 18, 2013 - 9:17am
tags:
AbbVie, dividends
Dendreon Just Raised the Bar
Motley Fool
Friday, January 18, 2013 - 9:16am
tags:
Dendreon, Provenge
IPO could value Pfizer's Zoetis at up to $12.5 bln
Reuters
Friday, January 18, 2013 - 9:15am
tags:
Pfizer, animal health, IPO, Zoetis
EU agency confirms suspension of Merck cholesterol drug
Reuters
Friday, January 18, 2013 - 9:13am
tags:
Europe, Tredaptive, Merck
Abbott Earnings: An Early Look
Motley Fool
Friday, January 18, 2013 - 9:10am
tags:
earnings, Abbott Laboratories
BioCryst Makes A Small Recovery Following Last Year's Bad News
Seeking Alpha
Thursday, January 17, 2013 - 10:43am
tags:
Biocryst, BCX5191
FDA approves egg-free flu vaccine Flubok
Pharma Times, UK
Thursday, January 17, 2013 - 10:31am
tags:
FDA, flu vaccine, Flubok, Protein Sciences
Genentech takes Exelixis drug into Phase III melanoma trial
Bizjournals.com
Thursday, January 17, 2013 - 10:19am
tags:
Exelixis, Genentech, melanoma, Roche, Zelboraf, GDC-0973
Frustration Rises Over The Missing Sunshine Rules
Pharmalot
Thursday, January 17, 2013 - 10:18am
tags:
Physician Payment Sunshine Act
AstraZeneca Collaborates with Vanderbilt
Yahoo/Zacks.com
Thursday, January 17, 2013 - 10:17am
tags:
AstraZeneca
Amgen’s Aranesp for Anemia Fails to Help Heart Patients
Bloomberg
Thursday, January 17, 2013 - 8:47am
tags:
Amgen, Aranesp, anemia, heart failure
Bristol-Myers Squibb and Quest Diagnostics Facing Healthcare Hurdles
Wall St. Cheat Sheet
Thursday, January 17, 2013 - 8:44am
tags:
Quest Diagnostics, Bristol-Myers Squibb
Pfizer's Zoetis wins strong response for $3.65bn debut bond sale
Reuters
Thursday, January 17, 2013 - 8:40am
tags:
Pfizer, Zoetis, animal health
3 Make-or-Break Moments for Celsion in 2013
Motley Fool
Thursday, January 17, 2013 - 8:39am
tags:
Celsion, ThermoDox
What to Watch With Astex in 2013
Motley Fool
Thursday, January 17, 2013 - 8:37am
tags:
Astex, Dacogen
Amgen says it will spend $200M to build antibody drug manufacturing facility in Singapore
Yahoo/AP
Thursday, January 17, 2013 - 8:33am
tags:
Amgen, drug manufacturing, Singapore
Life Sciences: Upcoming Events for Week of January 13
Motley Fool
Wednesday, January 16, 2013 - 12:12pm
tags:
Achillion, NuPathe, Anacor
AstraZeneca Asks U.K. to Encourage Use of Blood-Thinner Brilique
Bloomberg
Wednesday, January 16, 2013 - 11:52am
tags:
AstraZeneca, UK, bloothinners, Brilique
3 Drug Launches You Need to Know in 2013
Motley Fool
Wednesday, January 16, 2013 - 11:18am
tags:
NPS Pharmaceuticals, Gattex, short bowel syndrome, Iclusig, Ariad, chronic myeloid leukemia, Pfizer, Eliquis, Bristol-Myers Squibb

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.